FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37041911000001102: Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
47041000001113 Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
47051000001111 Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml Has AMP Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml Is a Azithromycin 200mg/5ml oral suspension 15 ml true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Azithromycin true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml Has specific active ingredient Azithromycin true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 15 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start